Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anula Jayasuriya files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian M. Culley - $24K in LCTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anula Jayasuriya?
Anula Jayasuriya is a corporate insider of Lineage Cell Therapeutics, Inc. (LCTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Anula Jayasuriya last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 3 filings going back to 2024.
